Mark Burgess Keatley

Mark Burgess Keatley

Directeur/Membre du Conseil chez KARO PHARMA AB (PUBL)
69 ans
Health Technology
Consumer Services
Non-Energy Minerals

Profil

Mr. Mark B. Keatley is an Independent Director at Karo Healthcare AB, a Member at The Chartered Institute of Management Accountants and a Principal at Ridgemark Advisors.
He is on the Board of Directors at Recipharm AB, Karo Healthcare AB and Medichem SA. Mr. Keatley was previously employed as a Chief Financial Officer by STADA Arzneimittel AG, a Member-Supervisory Board by Play Topco SA, a Partner by Albrecht Prock & Partners AG, a Chief Financial Officer by Actavis Group hf, an Independent Director by King Global Ventures, Inc., a Chief Financial Officer by Famar SA, a Chief Financial Officer by Ardana Bioscience Ltd., a Chief Financial Officer by Ashanti Goldfields Co. Ltd., a Division Manager by International Finance Corp., and a Chief Financial Officer by Actavis SARL. He received his graduate degree from the University of Cambridge and an MBA from Stanford Graduate School of Business.

Postes actifs de Mark Burgess Keatley

SociétésPosteDébut
RECIPHARM AB (PUBL) Directeur/Membre du Conseil 01/01/2021
KARO PHARMA AB (PUBL) Directeur/Membre du Conseil 01/01/2021
Corporate Officer/Principal -
Ridgemark Advisors
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de Mark Burgess Keatley

SociétésPosteFin
STADA ARZNEIMITTEL Directeur Financier/CFO 01/02/2020
Corporate Officer/Principal 01/01/2017
Directeur Financier/CFO 01/01/2012
Directeur Financier/CFO 01/01/2005
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mark Burgess Keatley

Formation de Mark Burgess Keatley

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

90

Relations au 1er degré

17

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées17

Non-Energy Minerals

Government

Consumer Services

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Non-Energy Minerals

Health Technology

Ardana Bioscience Ltd.

Actavis SARL

Consumer Services

Finance

Ridgemark Advisors

Commercial Services

  1. Bourse
  2. Insiders
  3. Mark Burgess Keatley
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇